Terminology Service for NFDI4Health
JSON

Binetrakin

Go to external page http://purl.obolibrary.org/obo/NCIT_C589

A recombinant agent chemically identical to or similar to the endogenous cytokine interleukin-4 (IL-4). Produced primarily by activated T-cells, IL-4 binds to and activates its cell-surface receptor, stimulating the proliferation and differentiation of activated B-cells and enhancing their ability to present antigens to T-cells. As a potential immunotherapeutic agent, recombinant IL-4 also augments the effects of other cytokines on dendritic cells (DC), cytotoxic T lymphocytes (CTL), and tumor-infiltrating lymphocytes (TIL). [ ]

Term info

Label

Binetrakin

Synonyms
  • B Cell Proliferating Factor
  • B-Cell Growth Factor
  • B-Cell Stimulating Factor
  • B-Cell Stimulatory Factor 1
  • BCGF
  • BCSF 1
  • Binetrakin
  • IL-4
  • INTERLEUKIN 4 HUMAN
  • Interleukin 4 (Human) 129
  • Interleukin-4
  • MCGF 2
  • Mast Cell Growth Factor-2
  • RHIL-4
  • Recombinant Human IL-4
  • SCH 93400
  • T-Cell Growth Factor 2
Subsets

NCIT_C63923, NCIT_C128784, NCIT_C157711, NCIT_C157712

CAS Registry

207137-56-2

FDA UNII Code

751635Z921

Legacy Concept Name

Therapeutic_Interleukin-4

NSC Code

618085, 620211

Preferred Name

Binetrakin

Semantic Type

Pharmacologic Substance, Amino Acid, Peptide, or Protein, Immunologic Factor

UMLS CUI

C1522540

code

C589